These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 31550244)

  • 1. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
    Zhang L; Zhou D; Li J; Yan X; Zhu J; Xiao P; Chen T; Xie X
    Med Sci Monit; 2019 Sep; 25():7182-7190. PubMed ID: 31550244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
    Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
    BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
    Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
    Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model.
    Idriss NK; Sayyed HG; Osama A; Sabry D
    Cell Physiol Biochem; 2018; 48(5):2161-2171. PubMed ID: 30114694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats.
    Fathy M; Okabe M; Saad Eldien HM; Yoshida T
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31952158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats.
    Shao CH; Chen SL; Dong TF; Chai H; Yu Y; Deng L; Wang Y; Cheng F
    J Surg Res; 2014 Jan; 186(1):408-16. PubMed ID: 24071025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.
    Rengasamy M; Singh G; Fakharuzi NA; Siddikuzzaman ; Balasubramanian S; Swamynathan P; Thej C; Sasidharan G; Gupta PK; Das AK; Rahman AZA; Fakiruddin KS; Nian LM; Zakaria Z; Majumdar AS
    Stem Cell Res Ther; 2017 Jun; 8(1):143. PubMed ID: 28610623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis.
    Mazhari S; Gitiara A; Baghaei K; Hatami B; Rad RE; Asadirad A; Joharchi K; Tokhanbigli S; Hashemi SM; Łos MJ; Aghdaei HA; Zali MR; Ghavami S
    Eur J Pharmacol; 2020 Sep; 882():173263. PubMed ID: 32535098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages of adipose tissue stem cells over CD34
    De Luna-Saldivar MM; Marino-Martinez IA; Franco-Molina MA; Rivera-Morales LG; Alarcón-Galván G; Cordero-Pérez P; Rojas-Martínez A; Rodríguez-Padilla C; Muñoz-Espinosa LE
    Ann Hepatol; 2019; 18(4):620-626. PubMed ID: 31147180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.
    Xuan J; Feng W; An ZT; Yang J; Xu HB; Li J; Zhao ZF; Wen W
    Mol Cell Biochem; 2017 May; 429(1-2):113-122. PubMed ID: 28181132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xuefuzhuyu decoction inhibition of angiogenesis attenuates liver fibrosis induced by CCl₄ in mice.
    Zhou YN; Sun MY; Mu YP; Yang T; Ning BB; Ren S; Chen JM; Liu P
    J Ethnopharmacol; 2014 May; 153(3):659-66. PubMed ID: 24637190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Anluohuaxianwan on transforming growth factor-β1 and related signaling pathways in rats with carbon tetrachloride-induced liver fibrosis].
    Lu W; Gao YH; Wang ZZ; Cai YS; Yang YQ; Miao YQ; Pei F; Liu XE; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):257-262. PubMed ID: 28494543
    [No Abstract]   [Full Text] [Related]  

  • 13. JinSanE decoction, a chinese herbal medicine, inhibits expression of TGF-beta1/Smads in experimental hepatic fibrosis in rats.
    Song SL; Gong ZJ; Huang YQ; Zhang QR; Huang TX
    Am J Chin Med; 2006; 34(6):1047-61. PubMed ID: 17163593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
    Rabani V; Shahsavani M; Gharavi M; Piryaei A; Azhdari Z; Baharvand H
    Cell Biol Int; 2010 Apr; 34(6):601-5. PubMed ID: 20178458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes.
    Luo XY; Meng XJ; Cao DC; Wang W; Zhou K; Li L; Guo M; Wang P
    Stem Cell Res Ther; 2019 Jan; 10(1):16. PubMed ID: 30635047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of forsythiaside A against CCl_4-induced liver fibrosis in mice and its mechanism].
    Guo Q; Zhang Y; Huang ZL; Lu B; Ji LL
    Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(22):6137-6145. PubMed ID: 36471938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis.
    Liu Y; Yang X; Jing Y; Zhang S; Zong C; Jiang J; Sun K; Li R; Gao L; Zhao X; Wu D; Shi Y; Han Z; Wei L
    Sci Rep; 2015 Dec; 5():17762. PubMed ID: 26643997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis.
    Su DN; Wu SP; Xu SZ
    Stem Cell Res Ther; 2020 Sep; 11(1):395. PubMed ID: 32928296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
    Motawi TM; Atta HM; Sadik NA; Azzam M
    Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice.
    Fang B; Shi M; Liao L; Yang S; Liu Y; Zhao RC
    Transplantation; 2004 Jul; 78(1):83-8. PubMed ID: 15257043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.